Clinical Trials in Sweden

• GSK4527226 Open-label Extension Study in Patients with Early Alzheimer's Disease. Ended
  2025-521107-42-00 Phase II Alzheimer's Disease Glaxosmithkline Research & Development Limited
• An open-label, randomized, single-dose, three-way crossover trial to evaluate the pharmacokinetics of nicotine pouch (NP) dry 4 mg compared … Ended
  2025-523879-34-00 Nicotine use Swedish Match North Europe AB
• An open, single arm, single-center, Phase 1 trial investigating the effect of 7-days-repeated administration of linaprazan glurate on the ph… Ended
  2024-518194-34-00 Phase I (Other) Helicobacter pylori infection, GERD Cinclus Pharma Holding AB (publ)
• A randomised, double-blind, placebo-controlled phase Ib trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of … Ended
  2025-522287-32-00 Phase I (Other) Depression AlzeCure Pharma AB
• Treatment of normal pressure hydrocephalus with acetazolamide Ended
  2024-514828-16-00 Phase II Normal pressure hydrocephalus Region Uppsala
• A phase III, international, multiCenter, randomized, paraLlel-group, Endoscopist-blinded non-inferiority study of the efficAcy, safety and p… Ended
  2025-521451-23-00 Phase III Subjects scheduled for elective colonoscopy performed accord… Ntc S.r.l.
• A prospective, double-blinded, randomized, placebo-controlled phase 1/2a study to assess safety, tolerability, systemic exposure and prelimi… Ended
  2024-517920-21-00 Phase I/II knee osteoarthritis Synartro AB
• A Study of PF-08046031 in Adults With Advanced Melanoma and Other Solid Tumors Ended
  2024-514745-10-00 Phase I Melanoma (or) malignant melanoma Non-small cell lung cancer … Pfizer Inc.
• A Phase 1 open-label positron emission tomography TRIAL to assess changes in liver uptake of [68Ga]Ga-FAPI-46 following oral administration … Ended
  2024-517605-91-00 Phase I (Other) advanced liver fibrosis AstraZeneca AB
• A randomised, open-label, 5-period, cross-over trial to assess the pharmacokinetics and safety of 3 oral solid formulations of buloxibutid (… Ended
  2025-520702-35-00 Phase I (Other) Idiopahtic pulmonary fibrosis Vicore Pharma AB
• A PilOt dose-escalation trial with EMP16 in preparation for Phase III – the POEM trial Ended
  2024-520122-11-00 Phase II Obesity Empros Pharma AB
• A phase 1, open-label trial in healthy subjects and in subjects with diabetes investigating pharmacokinetics, tolerability, safety, and food… Ended
  2024-515078-28-00 Phase I (Other) Diabetic Retinopathy Breye Therapeutics ApS
• A FIRST-IN-HUMAN PHASE I TRIAL OF OX118 IN HEALTHY VOLUNTEERS Ended
  2024-515378-28-00 Phase I Immune system Diseases Oxion Biologics AB
• An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporo… Ended
  2024-514496-18-01 Phase I (Other) Hepatocellular carcinoma, renal cell carcinoma and different… Disruptive Pharma AB
• An open-label, randomised, single-dose, three-way cross-over trial to assess the pharmacokinetics of NIC24-01 and NIC24-02 oromucosal pouche… Ended
  2024-514676-40-00 Phase I (Other) Nicotine dependence Niconovum AB
• Safety Trial, DSC vs. BAT in SR acute GvHD Ended
  2024-511768-97-01 Phase II Graft vs Host Disease Oslo Universitetssykehus HF
• Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization Ended
  2024-512651-20-00 Phase II Fetal and Neonatal Alloimmune Thrombocytopenia due to Human … Rallybio Ipa LLC
• A Phase 1/2 Study of VX-522 in Subjects with Cystic Fibrosis Ended
  2023-504786-23-00 Phase I (FiH) Cystic Fibrosis Vertex Pharmaceuticals Inc.
• A Study to assess the safety and potential use of GEH121224 (18F) Injection to visualise HER2-Receptor expression using PET imaging in patie… Ended
  2023-507720-23-00 Phase I/II Metastatic breast cancer GE Healthcare Limited
• A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as … Ended
  2024-511557-21-00 Phase III Major Depressive Disorder (MDD) with Moderate-to-severe Anhe… Janssen Cilag International
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom… Ended
  2024-512848-30-00 Phase II HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER Pfizer Inc.
• A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erec… Ended
  2024-515065-34-00 Phase II Erectile dysfunction (ED) Dicot AB
• Investigator initiated clinical trial of dantrolene as a treatment for Darier disease Ended
  2024-519201-36-00 Phase II Darier disease Karolinska University Hospital
• A multi-centre, randomised, single-blind Phase I/IIa study to evaluate the safety, tolerability and efficacy of a single topical dose of all… Ended
  2024-518757-42-00 Phase I/II Difficult-to-heal venous leg ulcers Xintela AB

Showing 865–888 of 1,115 trials